Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
79.2M
-
Number of holders
-
196
-
Total 13F shares, excl. options
-
78.4M
-
Shares change
-
+1.62M
-
Total reported value, excl. options
-
$3.8B
-
Value change
-
+$91M
-
Put/Call ratio
-
0.81
-
Number of buys
-
104
-
Number of sells
-
-96
-
Price
-
$48.44
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT) as of Q1 2023
242 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share as of Q1 2023.
PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT) has 196 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 78.4M shares
of 79.2M outstanding shares and own 98.93% of the company stock.
Largest 10 shareholders include FMR LLC (9.58M shares), VANGUARD GROUP INC (7.59M shares), RTW INVESTMENTS, LP (7.09M shares), WELLINGTON MANAGEMENT GROUP LLP (7M shares), BlackRock Inc. (6.27M shares), FRANKLIN RESOURCES INC (3.45M shares), JANUS HENDERSON GROUP PLC (3.2M shares), ARMISTICE CAPITAL, LLC (2.92M shares), STATE STREET CORP (2.91M shares), and Camber Capital Management LP (2.5M shares).
This table shows the top 196 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.